Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Carcinoma (mCRC)”

337 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 337 results

Not applicableLooking for participantsNCT06645236
What this trial is testing

DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
QIAGEN Gaithersburg, Inc 600
Not applicableStudy completedNCT02322736
What this trial is testing

Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR

Who this might be right for
Metastatic Colorectal Cancer
Amgen 218
Not applicableUnknownNCT04917276
What this trial is testing

Treatment Response Prediction System of mCRC Patients Based on CTC

Who this might be right for
Colorectal Cancer Stage IVCirculating Tumor Cell
Fudan University 100
Testing effectiveness (Phase 2)UnknownNCT03567629
What this trial is testing

Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

Who this might be right for
mCRC
Peking University 130
Not applicableNot Yet RecruitingNCT06655142
What this trial is testing

OSCAR II STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Colorectal Carcinoma (mCRC)
ExThera Medical Corporation 120
Testing effectiveness (Phase 2)Study completedNCT05025631
What this trial is testing

A Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment（DOFEMCRC）

Who this might be right for
Colorectal Cancer
Zhen-Yu Ding 29
Testing effectiveness (Phase 2)Looking for participantsNCT06324357
What this trial is testing

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Who this might be right for
Metastatic Breast CancerMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Boehringer Ingelheim 768
Testing effectiveness (Phase 2)Ended earlyNCT03563157
What this trial is testing

QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine

Who this might be right for
Colorectal Cancer MetastaticmCRC
ImmunityBio, Inc. 2
Not applicableWithdrawnNCT01631539
What this trial is testing

Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC

Who this might be right for
Liver MetastasesColorectal Cancer
Universitaire Ziekenhuizen KU Leuven
Testing effectiveness (Phase 2)Looking for participantsNCT07463599
What this trial is testing

Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Carcinoma (mCRC)Colorectal Cancer (CRC)Adenomatous Polyposis Coli (APC) Gene Mutation+1 more
HonorHealth Research Institute 126
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06835179
What this trial is testing

SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

Who this might be right for
Unresectable Metastatic Colorectal CancerMicrosatellite Stable (MSS) Colorectal Cancer (CRC)RAS-mutant Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 28
Not applicableStudy completedNCT04482608
What this trial is testing

The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival

Who this might be right for
Colorectal Cancer MetastaticMismatch Repair DeficiencyMicrosatellite Instability High
Sun Yat-sen University 671
Large-scale testing (Phase 3)Looking for participantsNCT07228832
What this trial is testing

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Summit Therapeutics 600
Large-scale testing (Phase 3)UnknownNCT01249638
What this trial is testing

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Who this might be right for
Colorectal Cancer Metastatic
Ludwig-Maximilians - University of Munich 516
Not applicableStudy completedNCT03665506
What this trial is testing

Trifluridin/tipirACil in MeTastatIc Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Servier 315
Not applicableUnknownNCT02631564
What this trial is testing

Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis

Who this might be right for
Colon Cancer Liver Metastasis
Fudan University 200
Testing effectiveness (Phase 2)Study completedNCT02469480
What this trial is testing

Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.

Who this might be right for
Metastatic Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 64
Early research (Phase 1)Study completedNCT01705002
What this trial is testing

Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.

Who this might be right for
CancerSolid TumorMetastatic Colorectal Cancer (mCRC)
Lipomedix Pharmaceuticals Inc. 88
Large-scale testing (Phase 3)Not Yet RecruitingNCT07004413
What this trial is testing

Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients

Who this might be right for
Colorectal Cancer Metastatic
Charite University, Berlin, Germany 267
Not applicableStudy completedNCT01528878
What this trial is testing

Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases

Who this might be right for
Liver NeoplasmsColonic NeoplasmsMetastatic Cancer to Liver
UNC Lineberger Comprehensive Cancer Center 30
Next Page